Literature DB >> 24014178

The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces mitochondrial and nuclear DNA damage in Caenorhabditis elegans.

Rakesh Bodhicharla1, Ian T Ryde, G L Prasad, Joel N Meyer.   

Abstract

The metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) form DNA adducts in animal models. While there are many reports of formation of nuclear DNA adducts, one report also detected NNK-induced damage to the mitochondrial genome in rats. Using a different DNA damage detection technology, we tested whether this finding could be repeated in the nematode Caenorhabditis elegans. We treated N2 strain (wild-type) nematodes with NNK in liquid culture, and applied quantitative PCR to analyze NNK-induced nuclear and mitochondrial DNA (mtDNA) damage. Our results confirm that NNK causes both nuclear and mtDNA damage. However, we did not detect a difference in the level of nuclear versus mtDNA damage in C. elegans. To test whether the mtDNA damage was associated with mitochondrial dysfunction, we used a transgenic nematode strain that permits in vivo measurement of ATP levels and found lower levels of ATP in NNK-exposed animals when compared with the unexposed controls. To test whether the lower levels of ATP could be attributed to inhibition of respiratory chain components, we investigated oxygen consumption in whole C. elegans and found reduced oxygen consumption in exposed animals when compared with the unexposed controls. Our data suggest a model in which NNK exposure causes damage to both C. elegans nuclear and mitochondrial genomes, and support the hypothesis that the mitochondrial damage is functionally important in this model. These results also represent a first step in developing this genetically tractable organism as a model for assessing NNK toxicity.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Caenorhabditis elegans; NNK; mitochondrial and nuclear DNA damage; tobacco

Mesh:

Substances:

Year:  2013        PMID: 24014178     DOI: 10.1002/em.21815

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  7 in total

1.  In Vivo Determination of Mitochondrial Function Using Luciferase-Expressing Caenorhabditis elegans: Contribution of Oxidative Phosphorylation, Glycolysis, and Fatty Acid Oxidation to Toxicant-Induced Dysfunction.

Authors:  Anthony L Luz; Cristina Lagido; Matthew D Hirschey; Joel N Meyer
Journal:  Curr Protoc Toxicol       Date:  2016-08-01

Review 2.  Cell Biology of the Mitochondrion.

Authors:  Alexander M van der Bliek; Margaret M Sedensky; Phil G Morgan
Journal:  Genetics       Date:  2017-11       Impact factor: 4.562

3.  Caenorhabditis elegans strain sensitivity to sodium arsenite exposure is varied based on age and outcome measured.

Authors:  Kathleen Hershberger; Tess Leuthner; Tanner Waters; Joel Meyer
Journal:  MicroPubl Biol       Date:  2019-10-22

Review 4.  The Effects of Capsaicin on Gastrointestinal Cancers.

Authors:  George Denis Alexandru Popescu; Cristian Scheau; Ioana Anca Badarau; Mihai-Daniel Dumitrache; Ana Caruntu; Andreea-Elena Scheau; Daniel Octavian Costache; Raluca Simona Costache; Carolina Constantin; Monica Neagu; Constantin Caruntu
Journal:  Molecules       Date:  2020-12-28       Impact factor: 4.411

5.  A fast and reliable method for monitoring genomic instability in the model organism Caenorhabditis elegans.

Authors:  Merle Marie Nicolai; Barbara Witt; Andrea Hartwig; Tanja Schwerdtle; Julia Bornhorst
Journal:  Arch Toxicol       Date:  2021-08-30       Impact factor: 5.153

6.  A Screenable In Vivo Assay for Mitochondrial Modulators Using Transgenic Bioluminescent Caenorhabditis elegans.

Authors:  Cristina Lagido; Debbie McLaggan; L Anne Glover
Journal:  J Vis Exp       Date:  2015-10-16       Impact factor: 1.355

7.  MPV17-related hepatocerebral mitochondrial DNA depletion syndrome (MPV17-NNH) revisited.

Authors:  Clifford Qualls; Mario Kornfeld; Nancy Joste; Abdul-Mehdi Ali; Otto Appenzeller
Journal:  eNeurologicalSci       Date:  2016-01-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.